EMA committee approves two more manufacturing sites for Pfizer-BioNTech Covid-19 vaccine
Photo: Collected.
The European health regulator's committee for human medicines(CHMP) on Tuesday approved two additional manufacturing sites, in Germany and Switzerland, for the production of the Covid-19 vaccine developed by Pfizer Inc and BioNTech.
Keep updated, follow The Business Standard's Google news channel
